Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 9.

Article

Snowden, J.A. orcid.org/0000-0001-6819-3476, Hawkey, C., Hind, D. orcid.org/0000-0002-6409-4793 et al. (17 more authors) (2019) Autologous stem cell transplantation in refractory Crohn’s disease – low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study. BMC Gastroenterology, 19 (1). 82. ISSN 1471-230X

Assadsangabi, A., Evans, C.A. orcid.org/0000-0003-4356-9216, Corfe, B.M. orcid.org/0000-0003-0449-2228 et al. (1 more author) (2019) Application of Proteomics to inflammatory bowel disease research: Current status and future perspectives. Gastroenterology Research and Practice, 2019. 1426954. ISSN 1687-6121

Snowden, J.A. orcid.org/0000-0001-6819-3476, Sharrack, B., Akil, M. et al. (5 more authors) (2018) Autologous haematopoietic stem cell transplantation (aHSCT) for severe resistant autoimmune and inflammatory diseases - a guide for the generalist. Clinical Medicine, 18 (4). pp. 329-334. ISSN 1470-2118

Sahnan, K., Tozer, P., Adegbola, S. et al. (17 more authors) (2018) Developing a core outcome set for fistulising perianal Crohn’s disease. Gut. ISSN 0017-5749

Tappenden, P. orcid.org/0000-0001-6612-2332, Ren, S., Archer, R. et al. (6 more authors) (2016) A Model-Based Economic Evaluation of Biologic and Non-Biologic Options for the Treatment of Adults with Moderately-to-Severely Active Ulcerative Colitis after the Failure of Conventional Therapy. PharmacoEconomics, 34 (10). pp. 1023-1038. ISSN 1170-7690

Rafia, R. orcid.org/0000-0002-6914-1990, Scope, A. orcid.org/0000-0003-1604-1758, Harnan, S. orcid.org/0000-0002-9318-9206 et al. (3 more authors) (2016) Vedolizumab for Treating Moderately to Severely Active Crohn’s Disease After Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. ISSN 1170-7690

Archer, R., Tappenden, P., Ren, S. et al. (8 more authors) (2016) Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model. Health Technoogyl Assessment, 20. 39. ISSN 1366-5278

Essat, M., Tappenden, P., Ren, S. et al. (5 more authors) (2015) Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. ISSN 1170-7690

Proceedings Paper

Marshall, J., Baker, D., Lee, M. orcid.org/0000-0001-9971-1635 et al. (3 more authors) (2017) Assessing internet based information used to aid patient decision making in surgery for perianal Crohn's fistula. In: Techniques in Coloproctology. East Midlands Surgical Society Summer Meeting, Leicester, UK. Springer , S428-S428.

This list was generated on Mon Oct 14 04:33:18 2019 BST.